4 results
The primary objective of the study is to confirm the clinical efficacy of epratuzumab in the treatment of subjects with moderate to severe general SLE despite standard of care treatments (ie, corticosteroids, and potentially antimalarials and…
Tiotropium is available in the pharmacy as solution for inhalation (daily dose of 5 mcg) and as inhalation powder (daily dose of 18 mcg). The objective of the present study is to compare three doses of tiotropum solution for inhalation (daily dose…
To attenuate the impact and duration of delayed graft funtion by dampening schemia reperfusion injury
To study the potential renoprotective effects of supplementation of alkaline phosphatase in hospitalized patients with AKI